{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:26:39Z","timestamp":1780496799235,"version":"3.54.1"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T00:00:00Z","timestamp":1514505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5K08AI093235-02"],"award-info":[{"award-number":["5K08AI093235-02"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0190332","type":"journal-article","created":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T18:34:47Z","timestamp":1514572487000},"page":"e0190332","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Immune activation despite preserved CD4 T cells in perinatally HIV-infected children and adolescents"],"prefix":"10.1371","volume":"12","author":[{"given":"Patricia","family":"Alvarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mussa","family":"Mwamzuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Marshed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Kravietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiina","family":"Ilmet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aabid","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Borkowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7316-4300","authenticated-orcid":true,"given":"Alka","family":"Khaitan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,12,29]]},"reference":[{"key":"ref1","unstructured":"UNAIDS. Fact Sheet July 2017: Global HIV Statistics. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.unaids.org\/en\/resources\/fact-sheet:\" xlink:type=\"simple\">http:\/\/www.unaids.org\/en\/resources\/fact-sheet:<\/ext-link> UNAIDS, 2017."},{"issue":"9441","key":"ref2","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0140-6736(04)17140-7","article-title":"Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis","volume":"364","author":"ML Newell","year":"2004","journal-title":"Lancet"},{"issue":"21","key":"ref3","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa0800971","article-title":"Early antiretroviral therapy and mortality among HIV-infected infants","volume":"359","author":"A Violari","year":"2008","journal-title":"N Engl J Med"},{"key":"ref4","article-title":"Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection","year":"2013","journal-title":"Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection","volume":"373","author":"ISS Group","year":"2015","journal-title":"N Engl J Med"},{"key":"ref6","first-page":"78","article-title":"Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV","year":"2015","journal-title":"Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV"},{"issue":"9904","key":"ref7","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/S0140-6736(13)61409-9","article-title":"Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial","volume":"382","author":"MF Cotton","year":"2013","journal-title":"The Lancet"},{"issue":"13","key":"ref8","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/QAD.0b013e328355d0ce","article-title":"Early antiretroviral therapy improves neurodevelopmental outcomes in infants","volume":"26","author":"B Laughton","year":"2012","journal-title":"AIDS"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S1473-3099(12)70242-6","article-title":"Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial","volume":"12","author":"T Puthanakit","year":"2012","journal-title":"The Lancet Infectious Diseases"},{"issue":"13","key":"ref10","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1097\/00002030-200309050-00006","article-title":"Persistent immune activation in HIV-1 infection is associated with progression to AIDS","volume":"17","author":"MD Hazenberg","year":"2003","journal-title":"AIDS"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/314660","article-title":"Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage","volume":"179","author":"JV Giorgi","year":"1999","journal-title":"J Infect Dis"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00042560-199710010-00003","article-title":"Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression","volume":"16","author":"Z Liu","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/00126334-200204010-00004","article-title":"Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection","volume":"29","author":"JV Giorgi","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1086\/427516","article-title":"T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection","volume":"191","author":"MP Eggena","year":"2005","journal-title":"J Infect Dis"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2249.1994.tb07015.x","article-title":"Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection","volume":"95","author":"L Kestens","year":"1994","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/aid.2008.0140","article-title":"Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression","volume":"25","author":"W Cao","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/infdis\/170.4.775","article-title":"CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group","volume":"170","author":"JV Giorgi","year":"1994","journal-title":"J Infect Dis"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1089\/aid.2013.0097","article-title":"Short communication: Evidence that microbial translocation occurs in HIV-infected children in the United Kingdom","volume":"29","author":"F Fitzgerald","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"9","key":"ref19","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/QAD.0b013e328339e228","article-title":"Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy","volume":"24","author":"MA Wallet","year":"2010","journal-title":"AIDS"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/INF.0b013e31824da0f5","article-title":"Increased gut microbial translocation in HIV-infected children persists in virologic responders and virologic failures after antiretroviral therapy","volume":"31","author":"S Pilakka-Kanthikeel","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/INF.0b013e31821d141e","article-title":"Increased microbial translocation in &lt;\/ = 180 days old perinatally human immunodeficiency virus-positive infants as compared with human immunodeficiency virus-exposed uninfected infants of similar age","volume":"30","author":"E Papasavvas","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1365-2249.2007.03526.x","article-title":"Immune reconstitution in human immunodeficiency virus type 1-infected children with different virological responses to anti-retroviral therapy","volume":"150","author":"A Anselmi","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/infdis\/jiq118","article-title":"Plasma levels of soluble CD14 independently predict mortality in HIV infection","volume":"203","author":"NG Sandler","year":"2011","journal-title":"J Infect Dis"},{"issue":"8","key":"ref24","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/infdis\/jiu238","article-title":"Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection","volume":"210","author":"PW Hunt","year":"2014","journal-title":"J Infect Dis"},{"key":"ref25","article-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection","year":"2016","journal-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection"},{"issue":"9396","key":"ref26","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(03)14793-9","article-title":"Group HIVPPMCS. Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis","volume":"362","author":"D Dunn","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/01.qai.0000223028.55080.9d","article-title":"Impact of inversion of the CD4\/CD8 ratio on the natural history of HIV-1 infection","volume":"42","author":"JB Margolick","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"e1003453","DOI":"10.1371\/journal.ppat.1003453","article-title":"The Th17\/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation","volume":"9","author":"MF Chevalier","year":"2013","journal-title":"PLoS Pathog"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"e1004078","DOI":"10.1371\/journal.ppat.1004078","article-title":"HIV-infected individuals with low CD4\/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality","volume":"10","author":"S Serrano-Villar","year":"2014","journal-title":"PLoS Pathog"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11904-013-0190-8","article-title":"Inflammatory co-morbidities in HIV+ individuals: learning lessons from healthy ageing","volume":"11","author":"AC Hearps","year":"2014","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"Suppl 1","key":"ref31","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/QAI.0000000000000267","article-title":"HIV and noncommunicable disease comorbidities in the era of antiretroviral therapy: a vital agenda for research in low- and middle-income country settings","volume":"67","author":"KM Narayan","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.idc.2014.05.003","article-title":"HIV-related metabolic comorbidities in the current ART era","volume":"28","author":"AH Warriner","year":"2014","journal-title":"Infect Dis Clin North Am"},{"issue":"22","key":"ref33","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"WM El-Sadr","year":"2006","journal-title":"N Engl J Med"},{"issue":"11","key":"ref34","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/QAD.0000000000000272","article-title":"Association between age at antiretroviral therapy initiation and 24-month immune response in West-African HIV-infected children","volume":"28","author":"S Desmonde","year":"2014","journal-title":"AIDS"},{"key":"ref35","article-title":"Aging and inflammation in patients with HIV infection","author":"M Nasi","year":"2016","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"ref36","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/QAD.0000000000001093","article-title":"Premature aging and immune senescence in HIV-infected children","volume":"30","author":"K Gianesin","year":"2016","journal-title":"AIDS"},{"issue":"11","key":"ref37","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1086\/522013","article-title":"Profile of T cell immune responses in HIV-infected children from Uganda","volume":"196","author":"I Ssewanyana","year":"2007","journal-title":"J Infect Dis"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1089\/aid.2011.0113","article-title":"Factors influencing T cell activation and programmed death 1 expression in HIV-infected children","volume":"28","author":"A Prendergast","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/COH.0000000000000231","article-title":"Immune activation and paediatric HIV-1 disease outcome","volume":"11","author":"JM Roider","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1056\/NEJM199402033300502","article-title":"Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery","volume":"330","author":"S Blanche","year":"1994","journal-title":"N Engl J Med"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1172\/JCI118419","article-title":"Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection","volume":"97","author":"A De Rossi","year":"1996","journal-title":"J Clin Invest"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"805151","DOI":"10.1155\/2012\/805151","article-title":"Suboptimal immune reconstitution in vertically HIV infected children: a view on how HIV replication and timing of HAART initiation can impact on T and B-cell compartment","volume":"2012","author":"N Cotugno","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"358","key":"ref43","doi-asserted-by":"crossref","first-page":"358ra125","DOI":"10.1126\/scitranslmed.aag1048","article-title":"Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infection","volume":"8","author":"M Muenchhoff","year":"2016","journal-title":"Sci Transl Med"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/jamainternmed.2014.4010","article-title":"Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals","volume":"175","author":"JF Okulicz","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"10","key":"ref45","doi-asserted-by":"crossref","first-page":"e1001542","DOI":"10.1371\/journal.pmed.1001542","article-title":"Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study","volume":"10","author":"MQ Picat","year":"2013","journal-title":"PLoS Med"},{"issue":"11","key":"ref46","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1086\/587900","article-title":"Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting","volume":"46","author":"K Patel","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/QAD.0b013e32834171db","article-title":"Younger age at HAART initiation is associated with more rapid growth reconstitution","volume":"25","author":"CJ McGrath","year":"2011","journal-title":"AIDS"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0190332","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T01:10:03Z","timestamp":1588986603000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0190332"}},"subtitle":[],"editor":[{"given":"Douglas F.","family":"Nixon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,12,29]]},"references-count":47,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0190332","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,29]]}}}